ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Pfizer Initiates Study of Vupanorsen americanpharmaceuticalreview
November 12, 2020Ionis Pharmaceuticals and its wholly owned subsidiary Akcea Therapeutics announced Pfizer has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-LRx) in statin-treated patients with elevated non-high-density lipoprotein cholesterol (non-HDL-C) and .. -
Ionis and Akcea announce that Pfizer initiated clinical study of vupanorsen pharmaceutical-business-review
November 06, 2020Ionis Pharmaceuticals and its wholly owned subsidiary Akcea Therapeutics, Inc., announced that Pfizer has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-LRx) in statin-treated patients with elevated non-high-density lipoprotein cholesterol ...
Pharma Sources Insight January 2025
